Treatment of neuroendocrine liver metastasis is limited to surgical removal of part of the liver, but clinicians do not have a clear understanding of what factors determine whether patients will have a good prognosis or a poor one. Equipped with this vital information, physicians and their patients could make much better-informed decisions about care.
Dr. Fabio Bagante and his team from Verona, Italy, developed a new tool that is able to accurately predict survival after liver surgery. In a blog posted on Healio Gastroenterology, Dr. Bagante explains the team’s approach in developing this “nomogram” and what factors the tool uses to make these predictions.
Dr. Bagante presented data from the study “Neuroendocrine Liver Metastasis: A Novel Nomogram Predicting the Prognosis of Patients after Liver Resection,” abstract 348, on Saturday, May 21, at 7:58 a.m. PT, in room 28AB of the San Diego Convention Center.